15 insiders reported 177 Form 4 transactions for ANI PHARMACEUTICALS INC (ANIP) over the past 18 months (most recent 2026-07-06). Recent activity: CAREY STEPHEN P. (SVP & CFO) Sell 3,313 shares, CAREY STEPHEN P. (SVP & CFO) Buy 3,313 shares, CAREY STEPHEN P. (SVP & CFO) Sell 2,850 shares, HAUGHEY THOMAS (Director) Buy 4,357 shares, TANNENBAUM RENEE P (Director) Buy 4,357 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,313 | $284,918 |
| 2026-07-06 | CAREY STEPHEN P. | SVP & CFO | Buy | 3,313 | $164,027 |
| 2026-06-30 | CAREY STEPHEN P. | SVP & CFO | Sell | 2,850 | $239,742 |
| 2026-06-10 | HAUGHEY THOMAS | Director | Buy | 4,357 | $0 |
| 2026-06-10 | TANNENBAUM RENEE P | Director | Buy | 4,357 | $0 |
| 2026-06-10 | Pera Antonio R | Director | Buy | 4,357 | $0 |
| 2026-06-10 | Leonard Matthew J | Director | Buy | 4,357 | $0 |
| 2026-06-10 | Thoma Jeanne | Director | Buy | 4,357 | $0 |
| 2026-06-10 | HAUGHEY THOMAS | Director | Sell | 2,000 | $161,760 |
| 2026-06-09 | CAREY STEPHEN P. | SVP & CFO | Buy | 3,312 | $163,977 |
| 2026-06-09 | CAREY STEPHEN P. | SVP & CFO | Sell | 3,312 | $264,960 |
| 2026-05-13 | Walsh Patrick D | Director | Sell | 3,973 | $320,820 |
| 2026-05-13 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Sell | 459 | $36,357 |
| 2026-05-13 | Lalwani Nikhil | PRESIDENT & CEO | Sell | 55,000 | $4.3M |
| 2026-05-13 | Gutwerg Ori | SVP, GENERICS | Sell | 2,772 | $220,374 |
| 2026-05-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $39,080 |
| 2026-05-13 | Walsh Patrick D | Director | Sell | 10,000 | $806,300 |
| 2026-04-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $38,975 |
| 2026-03-13 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Sell | 500 | $36,310 |
| 2026-03-13 | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | Sell | 4,772 | $357,471 |
| 2026-03-13 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,162 | $226,526 |
| 2026-03-10 | CAREY STEPHEN P. | SVP & CFO | Sell | 5,150 | $381,306 |
| 2026-03-10 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 2,121 | $157,421 |
| 2026-03-10 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,314 | $245,369 |
| 2026-03-10 | Mutz Christopher | HEAD OF RARE DISEASE | Sell | 3,602 | $267,196 |
Source: SEC Form 4 filings · as of 2026-07-06